|
2025
|
P/S
|
Therapeutic agents for the treatment of inflammatory diseases; therapeutic agents for the treatme... |
|
|
Invention
|
Stat6 inhibitors and uses thereof. The present disclosure provides compounds, compositions, and m... |
|
|
P/S
|
Therapeutic agents, namely pharmaceutical preparations for the treatment of atopic dermatitis, as... |
|
|
Invention
|
Irak4 degrader formulations and uses thereof. The present invention provides spray-dried formulat... |
|
|
Invention
|
Irak degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Stat6 degraders and uses thereof. The present disclosure provides compounds, compositions thereof... |
|
|
Invention
|
Smarca degraders and uses thereof.
The present invention provides compounds, compositions thereo... |
|
|
Invention
|
Mk2 degraders and uses thereof.
The present invention provides compounds, compositions thereof, ... |
|
2024
|
Invention
|
Stat3 degraders and their methods of use. The present invention relates to STAT3 degraders and me... |
|
|
Invention
|
Irak4 degraders and uses thereof.
The present invention provides IRAK4 degraders, formulations a... |
|
|
Invention
|
Irak4 degraders and synthesis thereof.
The present invention provides compounds, compositions th... |
|
|
Invention
|
Stat3 degraders for use in treating leukemia. The present invention relates to STAT3 degraders an... |
|
|
Invention
|
Stat6 inhibitors and uses thereof. The present invention provides compounds, compositions, and me... |
|
|
Invention
|
Stat6 inhibitors and uses thereof.
The present invention provides compounds, compositions, and m... |
|
|
Invention
|
Mdm2 degraders and uses thereof. The present invention relates to MDM2 degraders, their liquid fo... |
|
|
Invention
|
Dcaf1 ligands and uses thereof. The present disclosure provides small molecule pyrrole-3-carboxam... |
|
|
P/S
|
House mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune,... |
|
|
Invention
|
Stat3 degraders and uses thereof.
The present invention relates to STAT3 degraders, their liquid... |
|
|
Invention
|
Stat6 degraders and uses thereof. The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Irak4 degraders and uses thereof. The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Stat degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Cdk2 degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Irak degraders and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Stat3 degraders and uses thereof. The present invention relates to STAT3 degraders, their liquid ... |
|
|
Invention
|
Tyk2 degraders and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Salt forms of irak4 degraders. The present disclosure relates generally to various salt forms and... |
|
|
Invention
|
Mdm2 degraders and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Solid forms of mdm2 degraders. The present disclosure relates generally to various solid forms an... |
|
|
Invention
|
Deuterated mdm2 degraders and uses thereof. The present invention provides deuterium-enriched com... |
|
|
Invention
|
Crbn ligands and uses thereof.
The present invention provides compounds, compositions thereof, a... |
|
|
Invention
|
Tricyclic crbn ligands and uses thereof.
The present invention provides compounds, compositions ... |
|
2023
|
Invention
|
Methods of treating mutant lymphomas.
The present invention relates to methods of treating MYD88... |
|
|
Invention
|
Mdm2 degraders and uses thereof.
The present invention relates to MDM2 degraders, their liquid f... |
|
|
Invention
|
Protein degraders and uses thereof.
The present invention provides compounds, compositions there... |
|
2022
|
Invention
|
Tyk2 degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Mdm2 degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Bcl-xl degraders and uses thereof.
The present application relates novel bifunctional compounds,... |
|
|
P/S
|
Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncolog... |
|
|
P/S
|
Pharmaceutical and medical preparations for the treatment of
oncology, autoimmune, immune-oncolo... |
|
|
Invention
|
Deuterated irak degraders and uses thereof.
The present application provides novel bifunctional ... |
|
|
P/S
|
Pharmaceutical and medical preparations for the treatment of cancer, immune inflammatory diseases... |
|
2021
|
P/S
|
Pharmaceutical research and development; drug development and discovery services; medical and sci... |
|
|
Invention
|
Mdm2 degraders and uses thereof.
The present invention relates to compounds and methods useful f... |
|
2020
|
P/S
|
Research and development of therapeutic drugs for the treatment of
oncology, autoimmune, immune-o... |
|
2019
|
P/S
|
Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune oncolog... |
|
|
P/S
|
Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-o... |
